Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90110 ointment and LEO 29102 cream in the treatment of psoriasis vulgaris
2010-021941-38Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcipotriol + betamethasone and lotamilast in plaque psoriasis (4 arms), sponsored by LEO Pharma. Primary endpoint: Change in Total Clinical Score of target lesions. Started Nov 2010; status: terminated.
02
Drugs
calcipotriol + betamethasonelotamilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-021941-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021941-38.